RecruitingNot ApplicableNCT04932148
INCremental Dialysis to Improve Health Outcomes in People Starting Haemodialysis (INCH-HD)
The INCremental Dialysis to Improve Health Outcomes in People Starting Haemodialysis (INCH-HD) Study: a Randomised Controlled Trial
Sponsor
The University of Queensland
Enrollment
372 participants
Start Date
Jul 6, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
The INCH-HD trial will test if incremental HD preserves the quality of life of patients and families and is a safe, practical, cost effective treatment option.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Adults (≥ 18 years of age) and
- Commencing HD as their initial dialysis therapy and
- Able to give informed consent
Exclusion Criteria2
- Urine output <0.5Litres/day
- Unlikely to be on HD for ≥1 year.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERIncremental HD
Starting haemodialysis at twice weekly frequency
OTHERConventional HD
Starting haemodialysis at thrice weekly frequency
Locations(16)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04932148
Related Trials
A High Protein Egg White Pudding for People With Kidney Failure (HiPE KF)
NCT063437272 locations
Shingrix in Renal Transplant Recipients
NCT041281894 locations
STarting incrEmental Prescription of Peritoneal Dialysis
NCT066425976 locations
Erector Spinae Plane Block vs Quadratus Lumborum Block for Laparoscopic Nephrectomy
NCT062982271 location
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
NCT0467177121 locations